US Bancorp’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $87K | Sell |
4,203
-9,723
| -70% | -$229K | ﹤0.01% | 2530 |
|
|
2026
Q1 | $317K | Sell |
13,926
-207
| -1% | -$4.89K | ﹤0.01% | 1751 |
|
|
2025
Q4 | $377K | Sell |
14,133
-2,152
| -13% | -$63.6K | ﹤0.01% | 1689 |
|
|
2025
Q3 | $494K | Sell |
16,285
-2,123
| -12% | -$64.4K | ﹤0.01% | 1507 |
|
|
2025
Q2 | $577K | Sell |
18,408
-623
| -3% | -$20.6K | ﹤0.01% | 1417 |
|
|
2025
Q1 | $727K | Buy |
19,031
+462
| +2% | +$19.6K | ﹤0.01% | 1256 |
|
|
2024
Q4 | $815K | Buy |
18,569
+607
| +3% | +$26.7K | ﹤0.01% | 1225 |
|
|
2024
Q3 | $773K | Buy |
17,962
+4,050
| +29% | +$180K | ﹤0.01% | 1260 |
|
|
2024
Q2 | $629K | Buy |
13,912
+869
| +7% | +$45.1K | ﹤0.01% | 1350 |
|
|
2024
Q1 | $815K | Buy |
13,043
+447
| +4% | +$26.7K | ﹤0.01% | 1214 |
|
|
2023
Q4 | $706K | Buy |
12,596
+627
| +5% | +$31.3K | ﹤0.01% | 1304 |
|
|
2023
Q3 | $631K | Buy |
11,969
+2,258
| +23% | +$132K | ﹤0.01% | 1254 |
|
|
2023
Q2 | $623K | Sell |
9,711
-402
| -4% | -$22.9K | ﹤0.01% | 1276 |
|
|
2023
Q1 | $541K | Buy |
10,113
+2,921
| +41% | +$169K | ﹤0.01% | 1367 |
|
|
2022
Q4 | $385K | Buy |
7,192
+5,474
| +319% | +$283K | ﹤0.01% | 1532 |
|
|
2022
Q3 | $79K | Buy |
1,718
+245
| +17% | +$13.3K | ﹤0.01% | 2286 |
|
|
2022
Q2 | $81K | Sell |
1,473
-63
| -4% | -$4.06K | ﹤0.01% | 2344 |
|
|
2022
Q1 | $105K | Buy |
1,536
+93
| +6% | +$6.63K | ﹤0.01% | 2266 |
|
|
2021
Q4 | $114K | Sell |
1,443
-145
| -9% | -$12.1K | ﹤0.01% | 2238 |
|
|
2021
Q3 | $125K | Buy |
1,588
+134
| +9% | +$10.8K | ﹤0.01% | 2186 |
|
|
2021
Q2 | $114K | Buy |
1,454
+52
| +4% | +$3.98K | ﹤0.01% | 2239 |
|
|
2021
Q1 | $105K | Sell |
1,402
-9
| -0.6% | -$660 | ﹤0.01% | 2243 |
|
|
2020
Q4 | $93K | Buy |
1,411
+962
| +214% | +$56.2K | ﹤0.01% | 2243 |
|
|
2020
Q3 | $24K | Hold |
449
| – | – | ﹤0.01% | 2724 |
|
|
2020
Q2 | $22K | Sell |
449
-894
| -67% | -$39.5K | ﹤0.01% | 2771 |
|
|
2020
Q1 | $46K | Buy |
1,343
+208
| +18% | +$11.4K | ﹤0.01% | 2394 |
|
|
2019
Q4 | $71K | Buy |
1,135
+81
| +8% | +$4.58K | ﹤0.01% | 2323 |
|
|
2019
Q3 | $53K | Sell |
1,054
-16,025
| -94% | -$757K | ﹤0.01% | 2440 |
|
|
2019
Q2 | $824K | Buy |
17,079
+32
| +0.2% | +$1.54K | ﹤0.01% | 1157 |
|
|
2019
Q1 | $871K | Sell |
17,047
-2,638
| -13% | -$116K | ﹤0.01% | 1135 |
|
|
2018
Q4 | $708K | Buy |
19,685
+2,770
| +16% | +$129K | ﹤0.01% | 1169 |
|
|
2018
Q3 | $1.05M | Sell |
16,915
-71
| -0.4% | -$4.04K | ﹤0.01% | 1078 |
|
|
2018
Q2 | $896K | Buy |
16,986
+3
| +0% | +$162 | ﹤0.01% | 1167 |
|
|
2018
Q1 | $933K | Buy |
16,983
+3,565
| +27% | +$220K | ﹤0.01% | 1116 |
|
|
2017
Q4 | $914K | Sell |
13,418
-610
| -4% | -$41.1K | ﹤0.01% | 1136 |
|
|
2017
Q3 | $1M | Sell |
14,028
-1,766
| -11% | -$123K | ﹤0.01% | 1077 |
|
|
2017
Q2 | $1.07M | Buy |
15,794
+147
| +0.9% | +$10K | ﹤0.01% | 1025 |
|
|
2017
Q1 | $1.06M | Sell |
15,647
-258
| -2% | -$17.2K | ﹤0.01% | 1053 |
|
|
2016
Q4 | $984K | Sell |
15,905
-13,036
| -45% | -$770K | ﹤0.01% | 1074 |
|
|
2016
Q3 | $1.57M | Sell |
28,941
-205
| -0.7% | -$10.3K | 0.01% | 824 |
|
|
2016
Q2 | $1.33M | Buy |
29,146
+1,907
| +7% | +$93.2K | 0.01% | 869 |
|
|
2016
Q1 | $1.34M | Buy |
27,239
+1,581
| +6% | +$67.2K | 0.01% | 841 |
|
|
2015
Q4 | $1.03M | Buy |
25,658
+25,261
| +6,363% | +$1.16M | ﹤0.01% | 941 |
|
|
2015
Q3 | $20K | Buy |
397
+235
| +145% | +$15.6K | ﹤0.01% | 2853 |
|
|
2015
Q2 | $13K | Sell |
162
-92
| -36% | -$7.79K | ﹤0.01% | 3062 |
|
|
2015
Q1 | $21K | Sell |
254
-694
| -73% | -$58.1K | ﹤0.01% | 2923 |
|
|
2014
Q4 | $84K | Sell |
948
-1,008
| -52% | -$91.3K | ﹤0.01% | 2251 |
|
|
2014
Q3 | $191K | Sell |
1,956
-708
| -27% | -$79.5K | ﹤0.01% | 1788 |
|
|
2014
Q2 | $342K | Buy |
2,664
+174
| +7% | +$21.7K | ﹤0.01% | 1544 |
|
|
2014
Q1 | $306K | Buy |
2,490
+721
| +41% | +$82.8K | ﹤0.01% | 1558 |
|
|
2013
Q4 | $194K | Buy |
+1,769
| New | +$177K | ﹤0.01% | 1745 |
|
Other funds holding ENOV
RCMNY
DC
HRCM
US Bancorp's ENOV Position: Q2 2026 in Review
US Bancorp reduced its Enovis (ENOV) stake by 70% in Q2 2026, selling an estimated $229K and leaving 4,203 shares worth $87K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.
US Bancorp first reported a position in ENOV in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.57M in Q3 2016. 251 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.
- US Bancorp held 4,203 shares of Enovis worth $87K as of Q2 2026.
- US Bancorp sold 9,723 Enovis shares in Q2 2026, an estimated $229K.
- Enovis made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2530 holding.
- US Bancorp first reported a position in Enovis in Q4 2013 and has held it in 51 quarters since.
- US Bancorp's Enovis position peaked at $1.57M in Q3 2016.
- 251 funds tracked by Wall St. Rank held Enovis as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.